Qing-Nan Tang

19PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyPredictive and prognostic markersMolecular targetsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 25, 2026
Becotatug Vedotin Combined With Pucotenlimab in Platinum- and Immunotherapy-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma.

|Mar 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trial.

Li-Ting Liu, Xue-Song Sun, Ting-Ting Quan

|Mar 17, 2026
A selective enrichment and specific probe terminal mediated strategy for highly sensitive detection of microRNAs.

Zecheng Zhong, Weida Huang, Jinhua Ren

|Jul 02, 2025
AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex.

Sai-Lan Liu, Li Yuan, Xue-Song Sun

|Jun 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinoma.

Yi-Fu Li, Yu Chen, Hui Cheng

|Jun 13, 2025
GFH018 and Toripalimab Combination Therapy for Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: Results from a Phase Ib/II Study.

Lin-Quan Tang, Sai-Lan Liu, Muh-Hwa Yang

Pageof 4

Frequent Collaborators

6 joint publications

Linquan Tang

3 joint publications

Haiqiang Mai

3 joint publications

Qiu-Yan Chen

2 joint publications

Chong Zhao